• OPEN AN ACCOUNT
Indian Indices
Sensex
80,708.15 -291.25
( -0.36%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
58,738.13 1,303.36
(2.27%)
Nikkei 225
10,662.59 -120.07
(-1.11%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Astal Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
512600
INE307N01014
75.6664185
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
26.9
261.52
EPS(TTM)
Face Value()
Div & Yield %
2.22
10
0
 

hindustan unilever ltd
Remi Edelstahl Tubulars standalone net profit rises 164.29% in the March 2026 quarter
May 30,2026
Net profit of Remi Edelstahl Tubulars rose 164.29% to Rs 1.11 crore in the quarter ended March 2026 as against Rs 0.42 crore during the previous quarter ended March 2025. Sales rose 16.50% to Rs 47.44 crore in the quarter ended March 2026 as against Rs 40.72 crore during the previous quarter ended March 2025.

For the full year,net profit rose 2.62% to Rs 2.74 crore in the year ended March 2026 as against Rs 2.67 crore during the previous year ended March 2025. Sales rose 2.21% to Rs 141.62 crore in the year ended March 2026 as against Rs 138.56 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales47.4440.72 17 141.62138.56 2
OPM %6.324.32 -5.515.69 -
PBDT2.421.48 64 7.087.04 1
PBT1.590.54 194 3.723.53 5
NP1.110.42 164 2.742.67 3